RST-001
- Generic Name
- RST-001
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Background
RST-001 is a non-replicating recombinant adeno-associated virus vector containing a fragment of the gene encoding channel rhodopsin-2 protein.
- Associated Conditions
- -
- Associated Therapies
- -
RST-001 Phase I/II Trial for Advanced Retinitis Pigmentosa
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- AbbVie
- Target Recruit Count
- 14
- Registration Number
- NCT02556736
- Locations
- 🇺🇸
Retina Foundation of the Southwest, Dallas, Texas, United States
🇺🇸Duke Eye Center, Durham, North Carolina, United States
🇺🇸Cincinnati Eye Institute, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath